# Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology

> **NCT02822404** · NA · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 42 (actual)

## Conditions studied

- Kidney Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Urinary and blood sample for Cystatine dosage

## Key facts

- **NCT ID:** NCT02822404
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-17
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-05-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02822404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02822404, "Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT02822404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*